Alternative Pharmacologic Options for Nightmares When Clonidine and Prazosin Are Contraindicated
For PTSD-associated nightmares, consider trazodone, gabapentin, or cyproheptadine as first-line alternatives, while for non-PTSD nightmare disorder, triazolam or nitrazepam are reasonable options. 1
Treatment Algorithm Based on Nightmare Type
For PTSD-Associated Nightmares
The 2018 AASM guidelines list multiple pharmacologic agents that "may be used" when prazosin and clonidine are unavailable 1:
Primary alternatives:
- Trazodone (mean effective dose 212 mg/day): Reduced nightmare frequency from 3.3 to 1.3 nights/week in veterans, though 60% experienced side effects including daytime sedation, dizziness, and rarely priapism 1
- Gabapentin: Listed as acceptable option with "may be used" designation 1
- Cyproheptadine: Antihistamine with antiserotonergic properties, "may be used" designation 1
Secondary alternatives:
- Atypical antipsychotics (olanzapine, risperidone, aripiprazole): Consider if patient has comorbid psychotic symptoms or severe hyperarousal 1
- Tricyclic antidepressants: Useful if comorbid depression present 1
- Topiramate: "May be used" but monitor for cognitive side effects 1
- Fluvoxamine or phenelzine: Consider if comorbid depression/anxiety 1
- Nabilone (synthetic cannabinoid): "May be used" designation 1
For Non-PTSD Nightmare Disorder
Preferred pharmacologic options 1:
- Triazolam (short-acting benzodiazepine, half-life <5 hours): Reduced "unpleasant dreams" from 23 to 2 subjects in one trial 1
- Nitrazepam (longer-acting benzodiazepine, half-life 16-38 hours): Similar efficacy to triazolam 1
Important caveat: Clonazepam is specifically NOT recommended for nightmare disorder (showed no improvement in frequency or intensity) 1, and venlafaxine is also not recommended 1.
Critical Clinical Considerations
Avoid these common pitfalls:
- Do not use clonazepam—despite being a benzodiazepine like triazolam/nitrazepam, it showed no efficacy in controlled trials 1
- Do not use venlafaxine—explicitly not recommended by AASM guidelines 1
- Trazodone requires monitoring for priapism (occurred in 5 of 74 patients in one study) 1
Alternative Alpha-1 Blockers If Prazosin Specifically Contraindicated
If the issue is prazosin-specific (not class-wide contraindication), doxazosin emerges as the most promising alternative 2, 3, 4:
- Doxazosin 4-8 mg: Longer half-life than prazosin, reducing need for multiple daily doses
- Evidence shows 8 mg doxazosin resulted in 55.2% nightmare-free nights versus 4.3% without treatment (OR=28.2) 3
- In chart review of 51 patients, 25% achieved complete remission of nightmares at 12 weeks 4
- Better tolerated than prazosin with fewer hypotensive episodes 2
- Also effective in borderline personality disorder with nightmares 4
Other alpha-1 blockers with emerging evidence include terazosin and tamsulosin, though data is limited to case reports 5.
Prioritize Non-Pharmacologic Treatment
Image rehearsal therapy (IRT) is the ONLY treatment with "recommended" designation for both PTSD-associated nightmares and nightmare disorder 1. All pharmacologic options carry only "may be used" designations, indicating weaker evidence. Consider referring for IRT or other cognitive-behavioral interventions (CBT, exposure/relaxation/rescripting therapy) as these provide more durable benefits 1, 6.
Practical Initiation Strategy
- Determine nightmare etiology: PTSD-related versus idiopathic
- For PTSD nightmares: Start trazodone 50-100 mg at bedtime, titrate to 200-250 mg based on response
- For non-PTSD nightmares: Start triazolam 0.125-0.25 mg at bedtime
- If alpha-1 blocker needed but prazosin contraindicated: Start doxazosin 1-2 mg at bedtime, titrate to 4-8 mg
- Monitor: Blood pressure (for doxazosin), daytime sedation (for trazodone/benzodiazepines), priapism risk (for trazodone in males)
- Reassess at 4 weeks: If inadequate response, consider switching classes or adding psychotherapy